New research from the Hoskins and Hull Labs points to a promising new avenue for treating harmful fungal infections.
RNA splicing
Hoskins earns grant to study splicing inhibitors, connection to cancer
With a grant from the Edward P. Evans Foundation, biochemistry associate professor Aaron Hoskins is searching for new treatments for myelodysplastic syndromes — a type of blood cancer — by being able to screen for RNA splicing inhibitors using “humanized” yeast.